ACPE Numbers: Various – see listing below
Release Date: 6/1/2019
Expiration Dates: 6/1/2022
Activity Type: Application-based
CE Credits: 10 hours (ACPE)
Activity Fee: $200 (member) and $350 (non-member)
Accreditation for Pharmacists
APhA is accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.
These activities were recorded during a live educational event on March 22-25, 2019 in Seattle, WA. Learners who claimed credit for the live educational event, should not claim credit for this home study activity.
These activities are intended for Ambulatory Care pharmacists preparing to take the Board of Pharamcy Specialties BCACP certification exam.
This course is intended for Ambulatory Care pharmacists preparing to take the Board of Pharmacy Specialties (BPS) BCACP certification exam and is designed based on the content outline developed by BPS to provide an overview of recent standards and guidelines. This course uses a case-based approach to discuss patient care issues. In this series, faculty will:
- Review pertinent clinical topics and practice skills
- List valuable resources for further self-study
This online course consists of 7 activities and provides up to 10 hours of continuing pharmacy education. A practice exam is also included.
After participating in this CPE activity, learners should be able to:
Evidence Based Literature to Advancing Ambulatory Care Practice
ACPE Number: 0202-0000-19-127-H04-P
- Apply a systematic, step-wise approach to critically evaluating the primary research literature related to ambulatory care pharmacy practice.
- Identify the inherent limitations as well as potential confounders that impact the internal validity of observational studies.
- Interpret the results of a meta-analysis and analyze a Forest plot to determine the effect size, assess the heterogeneity of the included studies, and make a patient care recommendation.
- Determine the applicability of a study’s results and authors’ conclusions to your practice.
Deprescribing in the Geriatric Population
ACPE Number: 0202-0000-19-128-H01-P
- Define the rationale and significance of deprescribing in clinical care.
- Describe the interpersonal and clinical barriers to deprescribing.
- Construct a deprescribing plan for a patient suffering from polypharmacy.
- Review the role of motivational interviewing and share-decision making in the process of deprescribing.
Opioid Use Disorder Medication Assisted Treatment 101
ACPE Number: 0202-0000-19-129-H01-P
- Demonstrate an understanding of the mechanism of action for opioid use disorder (OUD) medication-assisted treatment (MAT) pharmacotherapy.
- Develop a patient-specific pharmacotherapy treatment plan for first-line treatment for OUD MAT.
- Construct a patient-specific pharmacotherapy treatment plan for MAT in patients with impaired drug clearance.
- Construct a patient-specific pharmacotherapy treatment plan for MAT in pregnant or lactating patients.
Incorporating Quality Improvement and Benchmarking Principles into your Ambulatory Care Practice
ACPE Number: 0202-0000-19-130-H04-P
- Define a clinical pharmacist’s scope of practice in ambulatory care settings and how it differentiates and complements an interprofessional care team.
- Establish benchmarks for pharmacist productivity and measurement in ambulatory care settings.
- Incorporate quality improvement principles into ambulatory pharmacy practice.
- Describe how to identify opportunities for quality improvement initiatives.
Managing Complex Patients and Hard-to-Control Hypertension
ACPE Number: 0202-0000-19-046-H01-P
- Explain recommendations from the newest American College of Cardiology/American Heart Association guideline for the treatment of patients with hypertension.
- Evaluate recent evidence assessing the efficacy of different blood pressure goals in hypertensive patients who present with and without comorbid conditions.
- Formulate a care plan for patients with resistant hypertension.
- Recommend appropriate medication regimens for the treatment of hypertension in patients with heart failure.
- Recommend appropriate medication regimens for the treatment of hypertension in frail elderly patients.
- Formulate patient-centered treatment plans for transplant patients with drug-induced hypertension.
Examining the Influence of Cardiovascular Outcome Trials: Is It the Heart of Diabetes?
ACPE Number: 0202-0000-19-064-H01-P
- Evaluate the potential benefits of antidiabetic drug therapy beyond lowering A1c effects.
- Summarize the results of cardiovascular outcome trials (CVOTs) of antidiabetic drug therapy.
- Design an individualized, evidence-based pharmacotherapeutic plan for a patient with type 2 diabetes.
- Recommend strategies for identifying and integrating into practice the results of new CVOT literature involving antidiabetic drug therapy.
Your Annual Cholesterol Management Update: Reducing ASCVD Risk
ACPE Number: 0202-0000-19-083-H01-P
- Discuss recent evidence-based updates in atherosclerotic cardiovascular disease (ASCVD) risk reduction and cholesterol management.
- Recommend treatment strategies for patients with hyperlipidemia who complain of statin-associated muscle symptoms.
- Discuss the evidence evaluating the efficacy and safety of nonstatin therapies in patients with dyslipidemia, including the impact on long-term cardiovascular outcomes.
- Describe recommendations for appropriate use of nonstatin therapies based on recommendations from authoritative national organizations.
- List investigational drug therapies for treatment of dyslipidemia.
- Formulate patient-centered treatment plans for patients with hyperlipidemia, beyond statin therapy
Molly J Ekstrand, RPh BCACP AE-C
Medication Management Pharmacist
Certified Ambulatory Care Pharmacist and Asthma Educator
Medication Management Program Manager
Park Nicollet Health Services
Michelle Geier, PharmD, BCPP, APh
Psychiatric Clinical Pharmacist Supervisor
San Francisco Department of Public Health
San Francisco, CA
Stuart T. Haines, Pharm.D., BCACP, BCPS, BC-ADM, FASHP
Professor and Director, Professional Pharmacy Development
University of Mississippi School of Pharmacy
Jennifer Pruskowski, PharmD, BCPS, BCGP, CPE
Assistant Professor, University of Pittsburgh School of Pharmacy
Palliative Care Clinical Pharmacy Specialist | UPMC Palliative and Supportive Institute (PSI)
Joseph Saseen, Pharm.D., BCACP, BCPS
Professor and Vice Chair
University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences
Clinical Pharmacy Specialist
University of Colorado Hospital, Department of Family Medicine
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, APhA requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
All faculty and planners for APhA education activities are qualified and selected by APhA and required to disclose any relevant financial relationships with commercial interests. APhA identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
- All faculty and planners report no financial relationships relevant to this activity.
Methods and CE Requirements
Activities consist of audio/video/PDF files, an attestation statement, and activity evaluation. Learners must review all content and complete the attestation statement and course evaluation to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit immediately after completing the activity.
System Technical Requirements
Learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.
- 128 MB of RAM 16-bit video card capable of 1024x768 screen resolution or better
- Speakers or headphones
- Microsoft Windows Users
- Microsoft Windows 98 SE, Windows NT 4.0 SP6a, Windows 2000 SP4, or Windows XP Service Pack 1,Service Pack 2, or Service Pack 3, Windows Vista, or Windows 7
- Internet Explorer 9.0 or later, Firefox 1.5 or later, or Chrome
- Apple Users
- Mac OS X 10.3 or later
- Safari, Firefox, or Chrome
- Additional software (for both Windows and Mac OS)
- Adobe Flash Player Version 10
- Adobe Acrobat Reader
- Key Settings
To ensure that you have the best learning experience possible. Please make sure your browser of choice is configured to allow for the following:
- Pop-ups Windows. Some security settings prevent pop-up windows from launching or open them in a "tab." In order to view learning activities at the optimal size, your system should allow pop-up windows to open as a free-standing window.
- Screen Space. Our multimedia activities require at least 990 pixels of side-to-side space and 650 of top-to-bottom space in the viewing window in order to display the content. Most systems with a screen resolution of 1024 x 768 meet this requirement. However, if you have multiple tool bars or other custom features you might not have enough screen space. The solution is to hide the toolbars or increase your screen resolution while participating in an activity.
These activities were developed by APhA.
To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-19-128-H01-P||0.1 CEUs||March 22, 2019 - March 22, 2022|
|ACPE# 0202-0000-19-127-H04-P||0.1 CEUs||March 22, 2019 - March 22, 2022|
|ACPE# 0202-0000-19-129-H01-P||0.1 CEUs||March 22, 2019 - March 22, 2022|
|ACPE# 0202-0000-19-130-H04-P||0.1 CEUs||March 22, 2019 - March 22, 2022|
|ACPE# 0202-0000-19-046-H01-P||0.2 CEUs||March 23, 2019 - March 23, 2022|
|ACPE# 0202-0000-19-064-H01-P||0.2 CEUs||March 24, 2019 - March 24, 2022|
|ACPE# 0202-0000-19-083-H01-P||0.2 CEUs||March 25, 2019 - March 25, 2022|